Atrial Fibrillation Health Literacy and Information Technology Trial in Rural PA Counties
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Arrhythmia, Cardiac
- Atrial Fibrillation
- Familial Atrial Fibrillation
- Heart Diseases
- Pathologic Processes
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Outcomes Assessor)Masking Description: Telephone assessors conducting the 8- and 12-month assessments will be masked.Primary Purpose: Health Services Research
Participation Requirements
- Age
- Between 21 years and 125 years
- Gender
- Both males and females
Description
This is a randomized clinical trial to evaluate the effect of a smartphone-based intervention called an embodied conversational agent (ECA) on health outcomes in people with atrial fibrillation. The study will enroll 264 patients who reside in rural, Western Pennsylvania who have atrial fibrillation...
This is a randomized clinical trial to evaluate the effect of a smartphone-based intervention called an embodied conversational agent (ECA) on health outcomes in people with atrial fibrillation. The study will enroll 264 patients who reside in rural, Western Pennsylvania who have atrial fibrillation. Participants will be randomized to the intervention or control. Intervention participants will receive a smartphone with a relational agent, which simulates conversation and provides coaching, guidance, and assistance with chronic disease self-management. In addition participants will receive an AliveCor Kardia for heart rate and rhythm monitoring, an FDA-approved, widely used instrument that pairs with the relational agent. Control participants will receive a smartphone with as well, which will have the health application WebMD. The intervention will last 4 months and participants will have visits at baseline, 4, 8 and 12 months. The study will evaluate the improvement in adherence to anticoagulation, quality of life, and health care utilization resulting from the intervention.
Tracking Information
- NCT #
- NCT04076020
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Northeastern University
- Boston University
- Investigators
- Principal Investigator: Jared W. Magnani, MD, MSc University of Pittsburgh
Get Well Soon